Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Evotec Guides 2025 Revenues At €760M–€800M, Adjusted EBITDA At €30M–€50M, R&D Spend Seen At €40M–€50M

Author: Benzinga Newsdesk | August 13, 2025 01:01am

Guidance for full-year 2025

  • Group revenues expected in a range of € 760 - 800 m (2024: € 797.0 m)
  • R&D expenditures are expected in a range of € 40 - 50 m (2024: € 50.9 m)
  • Adjusted Group EBITDA is expected to reach € 30 - 50 m (2024: € 22.6 m)

Posted In: EVO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist